Adamietz I A, Rahn R, Böttcher H D, Schäfer V, Reimer K, Fleischer W
Klinik für Strahlentherapie, J.-W.-Goethe-Universität Frankfurt a. M.
Strahlenther Onkol. 1998 Mar;174(3):149-55. doi: 10.1007/BF03038498.
Oral mucositis is a frequent complication of radiochemotherapy. The origin of radiation-induced mucosa lesions is of iatrogenic nature although further development of mucositis is essentially influenced by infection. It can be assumed that disinfection measures should decrease the severity of mucositis induced by radiochemotherapy. Therefore, in a prospective randomised study the efficacy of prophylactic oral rinsing with a disinfection agent was investigated.
An open, randomised, prospective comparative trial was conducted with 40 patients undergoing radiochemotherapy of head and neck region due to malignant disease. The treatment scheme consisted of irradiation to tumor region and adjacent lymph nodes with a total dose of 71.3 Gy and simultaneous chemotherapy with carboplatin (60 mg/m2) on days 1 to 5 and 29 to 34. In all patients, a prophylaxis of mucositis with nystatine, rutosides, panthenol and immunoglobulin was undertaken. In addition, 20 patients rinsed oral cavity 4 times daily with povidone-iodine-solution, the comparative group rinsed with sterile water. Clinical examination of the oral mucosa was performed weekly. Onset, grading and duration of mucositis were used as main variables.
Clinically manifested oral mucositis was observed in 14 patients of the iodine group (mean grading: 1.0) and all 20 patients of the control group (mean grading: 3.0). Total duration (mean) of clinically observed mucositis was 2.75 weeks in treatment patients and 9.25 in control patients. Median AUC (area under curve for grade vs duration) was 2.5 in iodine rinsing patients and 15.75 in control patients. All differences found between the 2 groups were statistically significant. Increased iodine incorporation was not observed. A pathological increase of thyroid hormone levels in the iodine group was not found.
The gained results indicate that incidence, severity and duration of radiochemotherapy-induced mucositis can be significantly reduced by oral rinsing with povidone-iodine performed additionally to the standard prophylaxis scheme.
口腔黏膜炎是放化疗常见的并发症。尽管黏膜炎的进一步发展主要受感染影响,但放射性黏膜损伤的起源具有医源性。可以推测,消毒措施应能降低放化疗所致黏膜炎的严重程度。因此,在一项前瞻性随机研究中,对使用消毒剂预防性口腔冲洗的疗效进行了调查。
对40例因恶性疾病接受头颈部放化疗的患者进行了一项开放、随机、前瞻性对照试验。治疗方案包括对肿瘤区域及相邻淋巴结进行照射,总剂量为71.3 Gy,并在第1至5天和第29至34天同时使用卡铂(60 mg/m²)进行化疗。所有患者均采用制霉菌素、芦丁、泛醇和免疫球蛋白预防黏膜炎。此外,20例患者每天用聚维酮碘溶液漱口4次,对照组用无菌水漱口。每周对口腔黏膜进行临床检查。黏膜炎的发病、分级和持续时间作为主要变量。
碘组14例患者出现临床表现的口腔黏膜炎(平均分级:1.0),对照组20例患者均出现(平均分级:3.0)。治疗组临床观察到的黏膜炎总持续时间(平均)为2.75周,对照组为9.25周。碘漱口患者的中位AUC(分级与持续时间的曲线下面积)为2.5,对照组为15.75。两组之间发现的所有差异均具有统计学意义。未观察到碘摄取增加。未发现碘组甲状腺激素水平病理性升高。
所得结果表明,在标准预防方案的基础上,用聚维酮碘进行口腔冲洗可显著降低放化疗所致黏膜炎的发生率、严重程度和持续时间。